Back to Authors

Matteson, E. L.

A5026833990 | I1330342723

Mayo Clinic

Citations 5

Effects of nintedanib in patients with progressive fibrosing interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in the INBUILD trial*

Pneumologie | June 8, 2022 | Volume: 76 | Issue: S 01 | Pages: S21-S21

10.1055/s-0042-1747733

Outpatient healthcare utilization among incident cases of systemic sclerosis: results from a population-based US cohort (1988–2016)

Scandinavian Journal of Rheumatology | July 7, 2021 | Volume: 51 | Issue: 4 | Pages: 323-328

10.1080/03009742.2021.1932581 | PMID 34232106

The Role of Janus Kinase 1 in TGF-Beta 1 Induced Fibroblast Trans-Differentiation

B64. MECHANISTIC ADVANCES IN LUNG FIBROSIS | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A4033-A4033

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4033

Circulating Protein Biomarkers in Rheumatoid Arthritis Associated Interstitial Lung Disease

A23. ILD PROGNOSIS AND BIOMARKERS I | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A1094-A1094

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1094

Single Cell Gene Expression in Classical Monocytes Correlates with Treatment Response to Tnf-Alpha Inhibition in Rheumatoid Arthritis

Journal of Investigative Medicine | May 10, 2016 | Volume: 64 | Issue: 4 | Pages: 976-976

10.1136/jim-2016-000120.135